Literature DB >> 3475267

The adverse effects of fluoroquinolones.

C R Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3475267     DOI: 10.1093/jac/19.6.709

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

1.  Absence of drug interaction between temafloxacin and low dose heparin.

Authors:  T Mant; P Morrison; E Millar
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

2.  Effects of ciprofloxacin on testosterone and cortisol concentrations in healthy males.

Authors:  N M Waite; D J Edwards; W S Arnott; L H Warbasse
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 3.  Fluoroquinolones. Adverse reactions during clinical trials and postmarketing surveillance.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

4.  Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.

Authors:  C Silvain; S Bouquet; J P Breux; B Becq-Giraudon; M Beauchant
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

6.  Fluorinated 4-quinolones induce hyperproduction of interleukin 2.

Authors:  K Riesbeck; J Andersson; M Gullberg; A Forsgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 7.  Clinical features and management of adverse effects of quinolone antibacterials.

Authors:  J H Paton; D S Reeves
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 8.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Clinical experiences with ofloxacin sequential therapy in chronic ear infections.

Authors:  W Heppt; H Lutz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 10.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.